Texas buyers look closely at certification, payer mix, referral concentration, staffing, and claims history. Because the state has no Certificate of Need law, a license alone usually does not create much scarcity value. Medicare certification and a strong record under the Review Choice Demonstration can improve buyer confidence. Smaller agencies may be discussed using revenue or blended measures until earnings are normalized. The confidential calculator can provide a starting point, but an advisor should review the underlying records before you rely on the range.

Texas regulates home-based care through the Home and Community Support Services Agency license issued by HHSC. Categories include licensed home health, licensed and certified home health, hospice, and personal assistance services. The category determines which services the agency may provide and which payers it can access, so it also shapes the buyer pool. Confirm the license category, survey status, and expiration dates before going to market. Buyers will check all three early in diligence.

Yes. Effective May 13, 2026, CMS imposed a nationwide six-month moratorium on initial Medicare enrollment applications for HHAs and hospices and included non-exempt changes in majority ownership. That means a proposed sale cannot be assumed to proceed as an ordinary transfer. HHSC requirements, Medicare enrollment history, the percentage and form of ownership changing, and any applicable federal exemption must be reviewed before the agency is marketed. The moratorium may be extended, lifted, or modified, so the current CMS notice and healthcare counsel should guide transaction structure.

A Texas sale can move quickly when the records and transaction path are clear, but several items can affect timing. These include buyer diligence, financing, HHSC filings, Medicare enrollment, and third-party consents. During the federal enrollment moratorium, some majority ownership changes may not be available. Organizing licenses, surveys, claims and RCD records, payer contracts, ownership history, staffing data, and normalized financials before outreach helps reduce avoidable delays.

We use a blind profile at the start of the process and require qualified buyers to sign an NDA before they receive identifying information. Staff, patients, and referral partners are not included until a transition plan is needed. You approve that plan. This approach helps protect census and referral relationships while buyers evaluate the agency.

Claims integrity is usually near the top of the diligence list because Texas participates in the Review Choice Demonstration and receives added hospice oversight. Buyers also review payer and referral concentration, including dependence on a single hospital system or STAR+PLUS contract. Staffing is the third major area, particularly retention, contract labor, and key clinical relationships. Clear records in each area make the agency easier to underwrite.